What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: New Frontiers
- 15 January 2010
- journal article
- conference paper
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 152A (2), 269-283
- https://doi.org/10.1002/ajmg.a.33189
Abstract
The NF Conference is the largest annual gathering of researchers and clinicians focused on neurofibromatosis and has been convened by the Children's Tumor Foundation for over 20 years. The 2009 NF Conference was held in Portland, Oregon from June 13 to June 16, 2009 and co‐chaired by Kathryn North from the University of Sydney and The Children's Hospital at Westmead, Sydney, Australia; and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts presented as posters; and three Keynote presentations. To date, there have been tremendous advances in basic research in the pathogenesis of neurofibromatosis, and more recently in progress toward identifying effective drug therapies and the commencement of neurofibromatosis clinical trials. The NF Conference attendees have significantly increased (doubling from 140 in 2005 to 280 attending in 2009) with a significant increase in attendance of physicians and clinical researchers. Correspondingly the NF Conference scope has expanded to include translational research, clinical trials and clinical management issues while retaining a core of basic research. These themes are reflected in the highlights from the 2009 NF Conference presented here.Keywords
This publication has 29 references indexed in Scilit:
- PAK kinase regulates Rac GTPase and is a potential target in human schwannomasExperimental Neurology, 2009
- Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival geneEMBO Molecular Medicine, 2009
- Neurofibromatosis type 2 (NF2): A clinical and molecular reviewOrphanet Journal of Rare Diseases, 2009
- The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulationCurrent Opinion in Genetics & Development, 2009
- Nf1 Mutation Expands an EGFR-Dependent Peripheral Nerve Progenitor that Confers Neurofibroma Tumorigenic PotentialCell Stem Cell, 2008
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Immunohistochemical Analysis Supports a Role for INI1/SMARCB1 in Hereditary Forms of Schwannomas, but Not in Solitary, Sporadic SchwannomasBrain Pathology, 2008
- Pten Haploinsufficiency Accelerates Formation of High-Grade AstrocytomasCancer Research, 2008
- The Loss of Nf1 Transiently Promotes Self-Renewal but Not Tumorigenesis by Neural Crest Stem CellsCancer Cell, 2008
- Germline Mutation of INI1/SMARCB1 in Familial SchwannomatosisAmerican Journal of Human Genetics, 2007